Two novel amphomycin analogues from Streptomyces canus strain FIM-0916

Natural Product Research

Volumn 28, Issue 12, 2014, Pages 861-867

  Yang, Huang Jian ^a   Huang, Xiao Zhen ^b   Zhang, Zhu Lan ^a   Wang, Chuan Xi ^a   Zhou, Jian ^a   Huang, Kai ^a   Zhou, Jing Ming ^a   Zheng, Wei ^a,b  

^a FUJIAN INSTITUTE OF MICROBIOLOGY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Amphomycins; Aspartocins; Lipopeptide antibiotics; NMR spectroscopy; Structure elucidation

Indexed keywords

AMFOMYCIN; ASPARTOCIN D; ASPARTOCIN E; DAPTOMYCIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; CARBON NUCLEAR MAGNETIC RESONANCE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; ENGYODONTIUM; ESCHERICHIA COLI; FERMENTATION; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS; STEREOCHEMISTRY; STREPTOMYCES; STREPTOMYCES CANUS;

POSIBACTERIA; STREPTOMYCES CANUS;

AMPHOMYCINS; ASPARTOCINS; LIPOPEPTIDE ANTIBIOTICS; NMR SPECTROSCOPY; STRUCTURE ELUCIDATION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; CALCIUM; GRAM-POSITIVE BACTERIA; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES, CYCLIC; STREPTOMYCES;

EID: 84903732322     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2014.886210     Document Type: Article

References (15)

1. Craig WA, Andes D, Stamstad T. 2010. In-vivo pharmacodynamics of MX-2401. Antimicrob Agents Chemother. 54:5092-5098.
2. Debono M, Abbot BJ, Molloy RM, Fukuda DS, Hunt AH, Daupert VM, Counter FT, Ott JL, Carrell CB, Howard LC, et al. 1988. Enzymatic and chemical modifications of lipopeptide antibiotic A21978C: the synthesis and evaluation of daptomycin (LY146032). J Antibiot. 41:1093-1105.
3. Diederen BM, Van Duijn I, Willemse P, Kluytmans JA. 2006. In vitro activity of daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains. Antimicrob Agents Chemother. 50:3189-3191. (Pubitemid 44396436)
4. Dugourd D, Siu R, Fenn J, Cameron DR, Boyd VA, Borders DB, et al. 2005. Novel lipopeptide amphomycin derivatives have activity against resistant and sensitive Gram-positive bacteria. In: Abstracts of the 105th General Meeting of the American Society for Microbiology; 2005 Jun 5-9; Atlanta, GA. Washington, DC: ASM Press [AbstractA- 086].
5. Dugourd D, Siu R, Fenn J, Cameron DR, Boyd VA, Wacowich-Sgarbi S, Sgarbi PWM, Jia Q, Clement JJ. 2006. In vitro characterization of MX-2401 - a novel amphomycin derivative active against Gram positive bacteria. In: Abstracts of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2006 Sep 27-30; SanFrancisco, CA. Washington, DC: ASM Press [Abstract F1-1879].
6. Dugourd D, Yang H, Elliott M, Siu R, Clement JJ, Straus SK, Hancock RE, Rubinchik E. 2011. Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant. Antimicrob Agents Chemother. 55:3720-3728.
7. Fujino M. 1965. On glumamycin, a new antibiotic. VI. An approach to the amino acid sequence. Bull Chem Soc Jpn. 38:517-522.
8. Heinemann B, Kaplan MA, Muir RD, Hooper IR. 1953. Amphomycin, a new antibiotic. Antibiot Chemother. 3:1239-1242.
9. Kong F, Janota K, Ashcroft JS, Carter GT. 2010. Structures of the Aspartocin Antibiotics - a consideration of requirements for cyclopeptide structures. Rec Nat Prod. 4:131-140.
10. Lomakina NN, Brazhnikova MG. 1959. The composition of crystallomycin. Biokhimiia. 24:425-431.
11. Naganawa H, Hamada M, Maeda K, Okami Y, Takeuchi T, Umezawa H. 1968. Laspartomycin, a new antistaphylococcal peptide. J Antibiot. 21:55-62.
12. Pasetka CJ, Erfle DJ, Cameron DR, Clement Jacob J, Rubinchik E. 2010. Novel antimicrobial lipopeptides with long in vivo half-lives. Int J Antimicrob Agents. 35:182-185.
13. Shoji J, Otsuka H. 1969. Studies on tsushimycin. II. The structures of constituent fatty acids. J Antibiot. 22:473-479.
14. Tanaka H, Oiwa R, Matsukura S, Inokoshi J, Omura S. 1982. Studies on bacterial cell wall inhibitors. X. Properties of phospho-N-acetylmuramoyl- pentapeptide-transferase in peptidoglycan synthesis of Bacillus megaterium and its inhibition by amphomycin. J Antibiot. 35:1216-1221. (Pubitemid 13256019)
15. Vertesy L, Ehlers E, Kogler H, Kurz M, Meiwes J, Seibert G, Vogel M, Hammann P. 2000. Friulimicins: novel lipopeptide antibiotics with peptidoglycan synthesis inhibiting activity from Actinoplanes friuliensis sp. nov. II. Isolation and structural characterization. J Antibiot. 53:816-827.